Clinical Trial Update: A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and tolerability of combining N-acetylcysteine with pirfenidone in idiopathic pulmonary fibrosis; the trial has completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2016-05-20